Seminar: Strategies for drug development2 Mar 2018
May 3. 12.00 - 17.30. AstraZeneca Gothenburg conference center.
CELLINK establishes R&D lab in AstraZeneca’s BioVentureHub17 Jan 2018
New lab to specialize in oncology research, as well as bioprinted lung and heart tissue models
Ectin Research joins BioVentureHub22 Dec 2017
Cancer therapy company gearing up to enter clinical development
Three new companies join the BioVentureHub24 Nov 2017
In Singulo Solutions, OnDosis and RLS Global have moved in
BVH company update7 Nov 2017
i-Tech's Selektope® antifouling technology adopted in new outfitting coating
Introducing OnDosis, a new life science company18 Oct 2017
AstraZeneca and GU Ventures have founded OnDosis together with entrepreneurial CEO, Martin Olovsson.
In the news12 Oct 2017
Billion kronor investment in life science cluster next to AstraZeneca Göteborg presented today by Next Step och Vectura
NLS Days 201710 Oct 2017
Check out this video summary featuring GE Healthcare, SWELife and BioVentureHub